Our CEO is an invited speaker at VIB Conference "Next-generation mRNA vaccines against complex pathogens"

The advent of mRNA technology has opened a new era of possibilities for tackling infections resulting from complex pathogens like bacteria and parasites. The VIB conference "Next-generation mRNA vaccines against complex pathogens: From antigen selection to clinical translation" will focus on the state of the art in mRNA vaccine development against such pathogens, with sessions spanning the entire development process. The topics covered will include antigen identification strategies, mRNA design & production, vaccine formulation, and pathogen-specific mRNA vaccine development progress. There will also be a dedicated session for Mycobacterium tuberculosis, given its distinction as the deadliest infectious pathogen in the world and the ongoing challenges in effective vaccine design for this important pathogen.

The conference will feature keynote lectures by Dr. Drew Weissman and Dr. Pieter Cullis, pioneers in the field of mRNA-based nanomedicines, as well as insights from other leading experts from academia and industry. Together, these contributions will provide a comprehensive overview of the current landscape and future directions of mRNA vaccines against complex pathogens.

Our CEO, Sander Wuyts, is an invited speaker and will be speaking on 25 March on the topic of:

Mapping the T-cell response with immunoinformatics: Connecting Antigen Presentation to TCR Specificity

‍